Autres langues Bruker Corporation

Actions

BRKR

US1167941087

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
80,97 ^USD	+0,47%		+4,13%	+10,19%

26/04	Bruker améliore encore son portefeuille de diagnostics en microbiologie clinique et en infectiologie lors de la conférence ESCMID Global 2024	CI
10/04	BRUKER CORPORATION : Goldman Sachs déconseille le dossier	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference	26/04
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference	26/04
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast	25/04
Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies	22/04
Bruker to Acquire the NanoString Business in an Asset Deal	22/04
Bruker Corporation entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $390 million.	17/04
Bruker : Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis in Applied, Industrial and Biopharma Laboratories	09/04
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates	08/04
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies	08/04
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies	08/04
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research	05/04
Bruker : Canopy Biosciences Announces the Launch of CellScape™ Whole-Slide Imaging Chamber for Spatial Biology	03/04
Bruker Corporation Enters into Term Loan Agreement with Bank of America, N.A	02/04
Bruker Selected as 'Company of the Year' by Instrument Business Outlook	02/04
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook	01/04
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO	11/03
Bruker Corporation Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO	11/03
Bruker Announces Closing of Chemspeed Technologies AG Acquisition	07/03
Bruker Corporation completed the acquisition of Chemspeed Technologies AG.	07/03
Bruker : Completes Acquisition of Optical Cell Imaging Company Phasefocus	04/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bruker Corporation

Actions

BRKR

US1167941087

Autres langues

Filtres